The New York Times has an article by
Andrew Pollack saying that
GlaxoSmithKline will contribute a total of twenty million dollars to start a research institute and a company with the goal of curing patients infected with
HIV.
Rico says it's a noble gesture that, if it works, will net
GSK vast multiples of that amount...
No comments:
Post a Comment
No more Anonymous comments, sorry.